Ascites Market – Global Industry Insights, Size, Share, Trends, Outlook Analysis 2017–2023

The Analysis presents the study of Worldwide Ascites facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold. The Global Ascites Market is expected to grow at a CAGR of 4.0% during the forecast period 2017-2023. Ascites is an abnormal accumulation of fluid in the abdominal cavity. Liver cirrhosis is the most common case of ascites. Its presence is a sign of significant portal hypertension. Other less common factors that may contribute to ascites development are heart failure, kidney failure, cancers, and infection in the pancreas. Malignant ascites has a characteristic role in the progression of ovarian cancer. Malignancy-related ascites have also been observed in malignancies of breast, lung, pancreas, gastric, and liver. Ascites can be detected by physical examination at a volume greater than 1.5 ascites. For a smaller amount of fluid, ultrasound and CT scan are preferred.
Notably, rising prevalence of cirrhosis is the key factors driving the Ascites Market. As per the study published in Hepatology journal in 2016, it is found that prevalence of the chronic liver disease is higher among Japanese Americans i.e. 6.9%. It is also stated that in whites, alcoholic liver disease was observed as the most common cause of cirrhosis i.e. 38.2%, whereas hepatitis C virus was most common in African Americans i.e. 29.8%
Improvement in reimbursement policies and increasing occurrence of cancer across the globe are also fuelling the market growth. According to a study published in the Cancer Biology & Medicine journal in 2017, it is found that ovarian cancer is the seventh most frequently diagnosed cancer among women in the world with an estimation of 239,000 new cases, and 152,000 deaths worldwide annually.
However, complications associated with ascites treatment may hinder the growth of the market over the forecast period. According to a study published in the Canadian Journal of Gastroenterology and Hepatology in 2016, serial large volume paracentesis (LVP) is considered as the first-line treatment for refractory ascites, and is also performed in an outpatient every 2 weeks. But there are certain complications associated with LVP such as bleeding, catheter fragmentation into the abdominal wall, and small bowel perforation.
Ascites Market Segmentation:
The Global Ascites Market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of the type, the market is classified into transudative ascites, and exudate ascites.
On the basis of the diagnosis, the market is segmented into ultrasound, CT scan, laparoscopy, angiography, and others.
On the basis of the treatment, the market is segmented into surgeries and others. The surgeries segment is further sub-segmented into peritoneovenous shunting, liver transplantation, transjugular intrahepatic portosystemic shunt (TIPS), and other surgeries.
On the basis of the end -users, the market is segmented into hospital, and clinics, ambulatory surgical centers, diagnostic centers, and others.
Ascites Market Key Players:
Some of key the players in the Ascites Market are Sequana Medical, BioVie, PharmaCyte Biotech Inc., Fresenius SE & Co. KGaA, BD, GI Supply, Medtronic plc, and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1909 .
Ascites Market Key Findings:
The Global Ascites Market is expected to reach USD 3710.4 million by 2023 at a CAGR of 4.0%.
On the basis of the diagnosis, the ultrasound segment is expected to command the largest market share of 9% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023
On the basis of the type, exudate ascites is expected to command the largest market share of 55.8% over the review period and it is also expected to grow at the fastest CAGR of 4.4% during the forecast period 2017-2023
The Americas hold the largest share of the global Ascites Market and is expected to reach USD 1,292.2 million by 2023
Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 4.5% over the 2017-2023
Ascites Market Regional Analysis:
The Americas dominate the Ascites Market owing to the well-developed technology, high healthcare expenditure, rising prevalence of cirrhosis, and the presence of the leading players in the region. According to the data suggested by the Centers for Disease Control and Prevention in 2015, around 1.6 % adults have been diagnosed with the chronic liver disease in the United States i.e. 3.9 million. It is also stated that from 2000 to 2015 death rates due to the chronic liver disease and cirrhosis was increased by 31% in the United States among individuals aged 45–64 years.
Europe holds the second position in the Ascites Market. It is expected that the support provided by the government bodies for research & development and increasing number of surgeries drives the market in this region. Liver is also very prevalent in European region. Owing to the increasing alcohol consumption and obesity, liver cirrhosis is the third most common cause of premature mortality in the UK as compared to other countries in Western Europe, suggested by a study published in BMJ Open in 2017
Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapidly improving technology and the presence of huge patient pool drive the growth of this market in Asia Pacific region.
The Middle East and Africa hold the least share of the Ascites Market owing to the presence of poor and slow developing countries, especially, in African region.
Major Table of Contents:
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Ascites Market By Types
7 Global Ascites Market By Diagnosis
8 Global Ascites Market By Treatment
9 Global Ascites Market By End Users
10 Global Ascites Market By Regions
11 Competitive Analysis
12 Conclusions
…Continued
Get Discount @ https://www.marketresearchfuture.com/check-discount/1909 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

MRFR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Years of research into diverse fields of work has ingrained within us, a proficiency so distinguished that our industry-specific specialists identify with your business ideas and feel the pulse of your challenges and opportunities. This enables us for providing assistance, through our consulting and strategic consulting services, in informed managerial decision making. In order to stay updated with technology and work process of the industries, WantStats Research and Media often conducts industrial visits for its research analysts. Relevant inputs from various established market participants, help our clients make significant contribution in respective markets are a huge motivation for all of us to endlessly furnish quality. We depend greatly on profound insights into complex realms of our study.

Pune, India

This release was published on openPR.